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Summary
BACKGROUND: The perioperative mortality rate (POMR)
is used as a quality indicator to monitor health care system
performance at regional and national levels. The Swiss
Federal Office of Public Health publishes national in-hos-
pital mortality rates for several indicator conditions and in-
dicator operation types (IORs). We investigated long-term
time trends of POMRs from 1998–2014. In view of con-
tinual advances in perioperative care, we expected to find
decreasing trends.
METHODS: Non-cardiosurgical IORs containing aggre-
gated age- and sex-specific data (number of operations
and deaths) for all years of the study period were included
to calculate age-standardised POMRs using the 2013 Eu-
ropean Standard Population. We assessed calendar time
trends of POMRs using multivariable Poisson regression.
We categorised IORs according to the type of time trend
(decreasing, unchanged, or increasing incident rate ratio)
and mean risk levels (age-adjusted POMR).
RESULTS: A total of 22 IORs were included, comprising
1,561,012 operations and 22,140 deaths (overall crude
POMR 1.42%). POMR trends decreased for 6 IORs rep-
resenting 26.8% of operations, remained unchanged for
13 IORs (56.9% of operations), and increased for 3 IORs
(16.4% of operations). IOR categorisation according to
POMR trends and to risk levels yielded four groups. (1)
Decreasing POMR trends, low- to intermediate-risk IORs
(age-adjusted POMR 0.2–2.2%): cholecystectomy; arte-
rial pelvic/leg aneurysm or dissection operation; femoral
neck fracture; trochanteric fractures; gastric, duodenal or
jejunal ulcer resection; major pulmonary or bronchial re-
section. (2) Unchanged POMR trends, low-risk IORs
(0.1–0.9%): transurethral resection of the prostate (TUR
prostate); hernia repair without intestinal operation; hys-
terectomy; extracranial vascular operation; nephrectomy;
amputation foot, non-traumatic. (3) Unchanged POMR
trends, intermediate-risk IORs (1.7–3.8%): hernia repair
with intestinal operation; gastric carcinoma resection; non-
ruptured abdominal aortic aneurysm (open operation); ar-
terial pelvic/leg thromboembolic operation; colorectal re-
section, pancreatic resection; complex oesophageal
procedure. (4) Increasing POMR trends, low- to high-risk
IORs (0.1–5.2%): hip endoprosthesis; cystectomy; ampu-
tation lower limb. Impact of sex on POMR: hysterecto-
my and TUR prostate comprised 19.7% of all operations;
among the remaining operations, 68.5% showed signifi-
cantly lower and 27.1% significantly higher POMRs in fe-
males. 4.4% showed no sex difference.
CONCLUSIONS: In Switzerland, in-hospital POMR trends
from 1998–2014 were unchanged or even increasing for
the majority of IORs (73% of included operations). Our
analysis used age-standardisation but cannot account for
changes in coding practices and organisation of health-
care delivery. POMR trends should be systematically mon-
itored at the national level and used to guide priorities in
national quality improvement strategies.
Keywords: perioperative mortality rate, time-trend analy-
sis, surgical mortality, surgical complications, Switzerland
Introduction
Perioperative mortality rates (POMRs) are increasingly
used as indicators of perioperative safety and quality at the
regional and national levels of healthcare [1–4]. POMRs
are usually reported as in-hospital or 30-day mortality
rates, and are recommended by the World Health Organi-
zation [5] and the Lancet Commission on Global Surgery
[6, 7] as core health indicators. POMRs that are based on
routinely collected mortality data help to monitor system
performance [1], to identify opportunities for improvement
and to assess the overall effects of quality and safety in-
terventions [8]. Studies have documented a substantial lev-
el of surgical in-hospital mortality (European average: 4%)
[9]. This may be related, in part, to adverse events, which
can affect up to 30% of surgical patients [10, 11]. More
than 50% of such adverse events have been estimated to
be preventable [12], which indicates room for quality im-
provement.
In Switzerland, the Federal Office of Public Health
(FOPH) publishes national in-hospital mortality rates (CH-
IQI) for a number of indicator conditions and procedures
[13], whereas national data about complications and ad-
verse events are limited [14]. Estimates of preventable pa-
tient harm and the strategies promoted to improve safety
and quality in Switzerland [15] are often based on interna-
tional literature [16, 17]. From a public health perspective,
it is important to know the POMR trends for defined sur-
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gical populations, such as patients undergoing procedures
belonging to the field of nationwide planned highly spe-
cialised medicine (HSM) [18]. Such trends are not a mea-
sure of overall perioperative quality, but they may help to
identify defined surgical patient groups deviating from ex-
pected outcomes, to generate hypotheses about potentially
modifiable risk factors and to set priorities for further in-
vestigations and the development of public health interven-
tions at the national level.
Based on the general advances in perioperative care, an
overall tendency of decreasing POMR trends should be ex-
pected. To our knowledge, national mortality trends for de-
fined surgical populations based on the CH-IQI data have
not been published to date. Therefore, we calculated and
analysed such trends after age-standardisation of POMRs
for different years for suitable surgical patient groups using
the routine data published by the FOPH. By formally test-
ing the hypothesis that long-term time trends of POMRs
are generally decreasing, we investigated whether the
trends of age-standardised POMRs for selected IORs were
constant, increasing, or decreasing over the study period.
Materials and methods
In line with Swiss federal law, the FOPH publishes freely
accessible in-hospital mortality data on the internet for a
number of medical indicator conditions and surgical indi-
cator procedures (CH-IQI) [13]. We based this study on da-
ta that are freely accessible on the websites of the Swiss
FOPH. We described time trends of POMRs after direct
age standardisation using the European Standard Popula-
tion [19]. In a second step, multivariable Poisson regres-
sion was used to formally analyse time trends of mortality
rates while adjusting for age and sex distribution [20, 21].
Data sources
Data collection pathway
Swiss hospitals are legally bound by the Federal Statistics
Act of 1992 (BStatG) and the Federal Act on Health In-
surance of 1996 (KVG) to report administrative and med-
ical data (including in-hospital deaths, main diagnoses and
main procedures) necessary for the publication of the med-
ical statistics of hospitals (“Medizinische Statistik der
Krankenhäuser”) by the Federal Statistical Office [22].
Mortality always defines a case as an “inpatient” hospital
stay [22]. Data are transferred from hospitals to the Can-
tonal Statistical Offices, from there to the Federal Statisti-
cal Office and to the FOPH [13] (see appendix 1 for de-
tailed description).
Swiss inpatient quality indicators (CH-IQIs) published by
the Federal Office of Public Health [23]
The FOPH publishes CH-IQIs for 49 selected indicator
disease patterns and procedures. Depending on the clinical
field, some CH-IQIs include information about case num-
bers, information about proportions (e.g., share of stroke
patients treated in a stroke unit), special features (e.g.,
length of stay), or age- and sex-specific mortality [13]. In
2014, the CH-IQIs covered 46% of all inpatient cases and
63% of inpatient deaths [13]. CH-IQIs are published on
a freely accessible website and present mortality as both
indicator-specific mortality and as standardised mortality
ratios (SMR) for individual hospitals [13, 23]. SMRs are
calculated using indirect standardisation and age- and sex-
adjustment as the ratio of observed deaths divided by the
expected deaths for a given indicator, where the expected
deaths is calculated as the number of indicator cases in the
hospital multiplied by the nationwide age- and sex-adjust-
ed mortality rate for the indicator (nationwide deaths di-
vided by nationwide cases) [13]. SMRs can be compared
for different indicators and hospitals using an internet tool
[23]. The nationwide reference data are published sepa-
rately as downloadable “.zip” files containing data in “.txt”
format for each indicator [24, 25]. The 2013 data set con-
tains data from 1998–2013 [24], and the 2014 data set con-
tains data from 2004–2014 [25]. Data from 2004–2013 are
overlapping in the two sets (for data checks, see below).
The “.txt” file names contain the description and definition
of the indicator according to the CH-IQI nomenclature [13,
24, 25]. For the purpose of the current analysis, these ref-
erence data sets were used. The observations in such data
sets include information on calendar year, age group, sex,
number of deaths per age group, number of cases (opera-
tions) per age group, and mortality rate (deaths/cases) per
age group.
Selection of indicator operations (IORs)
Rationale for the inclusion of indicators
The study period was defined as the years 1998–2014
based on (1) the earliest availability of data, and (2) start of
the research project in 2015/2016 (at this time, data were
available until 2014). During the 17-year study period, new
indicators were added by the FOPH, and the specifications
for calculating the data are constantly revised [13, 26]. For
the purposes of this analysis it was therefore important to
choose indicators that (1) were present in both data sets
used (see data sources 2013/2014, above), (2) contained
data for all years of the study period, and (3) had their re-
sults calculated with the same specification version (V4
[26]).
Clinical considerations
1. From the various information contained in the CH-
IQIs [13], only indicators containing data regarding
age- and sex-specific mortality were included.
2. Clinical setting: surgical patients usually share typical
care pathways, including preoperative assessment,
anaesthesia care, OR and (often) postoperative facil-
ities (postanaesthesia care units, intensive care units)
[9]. Due to these common features of surgical patients,
those undergoing nonsurgical invasive procedures or
interventions and conservative medical management
were not included in the study.
3. Noncardiac surgery: because of their separate and spe-
cific perioperative pathways [9] and in line with other
studies [9, 27, 28], cardiosurgical procedures were not
included.
4. Overall indicators: some FOPH indicators summarise
mortality data for a group of multiple operations re-
lated to a surgical area (e.g., “colorectal resections”).
If available, such overall indicators were included in-
stead of indicators describing one specific operation
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within the overall surgical group (e.g., “colorectal re-
sections for bowel ischaemia”).
Highly specialised medicine defined by the Swiss Confer-
ence of Cantonal Health Directors
In Switzerland, highly specialised medicine (HSM, includ-
ing medical fields and interventions) is characterised by
the following criteria: rarity, high potential for innovation,
high personnel or technical costs, or complex treatment
procedures [18]. In contrast to other fields of healthcare
that are organised in Switzerland by the individual cantons,
HSM is planned by the Swiss Conference of Cantonal
Health Directors (GDK) on a nationwide level with the ob-
jective to concentrate such services in order to improve
quality of care and to optimise efficiency [29]. Because of
the relevance of HSM for this analysis of nationwide mor-
tality data, HSM fields were reviewed in view of overlaps
with the selected IORs [30, 31]. The only HSM field found
to be relevant for this analysis was the field of complex
highly specialised visceral surgery [30, 31]. In this field,
procedure groups that overlapped with IORs fulfilling the
inclusion criteria were pancreatic resections, oesophageal
resections and low resection of the rectum. The latter con-
stitutes a part of the IOR group “colorectal resections”, but
cannot be separated within the FOPH data [31]. As com-
plex and highly specialised visceral surgery had been as-
signed to HSM in 2013, the current analysis (1998–2014)
may not capture trend-relevant effects of HSM-related in-
terventions.
Inclusion and exclusion criteria
Based on these considerations, indicators were included if
they met all of the following criteria: (1) were available in
both the 2014 and 2013 FOPH data sets; (2) contained da-
ta for all years studied (1998–2014); (3) were calculated
using the same specification version in all data sets (V4
[26]); (4) contained data about age- and sex-specific mor-
tality; (5) contained data about a surgical operative pro-
cedure; (6) contained data about a non-cardiosurgical pro-
cedure; /7) contained data about an overall indicator of a
surgical area or of a specific surgical operation subgroup if
no overall indicator was available.
Indicators were excluded from the analysis if they met one
or more exclusion criteria: (1) were not contained in the
2014 and 2013 FOPH data sets; (2) did not contain data for
all years studied (1998–2014); (3) had not been calculat-
ed using the same specifications (V4 [26]) in all data sets;
(4) contained no data about age- and sex-specific mortali-
ty; (5) contained no data about a surgical operative proce-
dure (in contrast to nonsurgical procedures or conservative
management); (6) contained data about a cardiosurgical (in
contrast to non-cardiosurgical) procedure; (7) contained no
data about an overall indicator of a surgical area (unless no
overall indicator was available).
The inclusion and exclusion criteria were checked in an
Excel spreadsheet using the indicator definitions in the .txt
files for individual IORs.
Ethical considerations
All data used for this analysis are anonymised and open
access. Their use for review, reanalysis and re-interpreta-
tion is not expected to pose ethical problems.Data import, 
clearance, preparation of files and variables
Data import, clearance, preparation of files and vari-
ables
The “.zip” files containing the 2013 and 2014 datasets 
were downloaded from the FOPH website [24, 25]. From 
“.txt” files for each IOR, data were imported using the Sta-
ta command “import delimited” [32]. Data for 1998–2003 
were imported from the 2013 set, and data for 2004–2014 
from the 2014 set (for the FOPH data structure see above; 
for data checks of the overlapping data and exceptions see 
below). Notably, age groups with no cases (stratum pop-
ulation = 0) are omitted in the FOPH data sets [24, 25]. 
However, from the data collection process and the presen-
tation on the FOPH website, it is clear that such obser-
vations are not “missing values” but are observations for 
which no cases have been reported according to the regu-
lar process (“omitted” rather than “missing” observations 
[33]). As the data analysis required complete age groups, 
missing groups were reconstructed (“rectangularised”)
[34] to show zero counts for files with these missing age 
groups (for details, see appendix 1).
Direct standardisation using the 2013 European Stan-
dard Population
Direct standardisation
Direct standardisation produces a set of standardised rates 
by applying the age–sex specific rates from the study pop-
ulations to a standard population [35]. In contrast to indi-
rect standardisation, direct standardisation gives more ac-
curate results in the case of small numbers of events in any 
of the age–sex groups of the population [35]. This method 
was chosen because the annual IOR populations compared 
in this analysis are independent populations, and the num-
ber of events (deaths) is relatively small (in the range of 
several percent). Directly standardised POMRs were cal-
culated using the Stata command “distrate” [36, 37], which 
calculates the standardised rates and their 95% confidence 
intervals (CIs). To calculate the 95% CIs, we used the 
method proposed by Dobson, Kuulasmaa [38] and imple-
mented in the “distrate” command [37]. For each IOR, 
we graphically show the overall crude and age-adjusted 
POMR and 95% boundaries [39, 40]. As a standard popu-
lation, the 2013 European Standard Population (ESP) [19] 
was used after minimal adaptation to the FOPH groups 
(see appendix 1 for detailed description).
Parameters for presentation of results
1. Sex versus gender
The FOPH data set contained a few sporadic cases of
male hysterectomy and female transurethral resection
of the prostate (TUR prostate), but it was not evident
whether these represented correct entries for patients
with differing genetic sex and gender (e.g., gender re-
assignment surgery [41], or TUR prostate after gender
reassignment surgery [42]) or were erroneous entries.
Therefore, sex- or gender-specific time trends were not
included in this analysis for TUR prostate or hysterec-
tomy cases.
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2. Classification of POMR levels
The classification of POMR levels was chosen in anal-
ogy to established definitions used for the classifica-
tion of surgical risk of major adverse cardiac events
(MACE). Low risk: estimated 30-day cardiac event
rates (cardiac death and myocardial infarction) of <1%
[43]; elevated risk: ≥1% [44]; intermediate risk: 1–5%
[43]; high risk: >5% [43, 45, 46]; extremely high risk:
>20% [45, 46].
3. Reporting format for POMR
As is often the case in clinical literature, perioperative
mortality rates were reported as percentages of the cor-
responding populations, and over a defined time peri-
od [9, 10, 47–50].
Time trend analysis using Poisson regression
Poisson regression
Poisson regression can be used to examine how incident
rates [20] differ between groups of people or between dif-
ferent exposure levels by estimating the incident rate ratios
adjusted for possible differences in age and sex distribu-
tions [20, 51]. Multivariable Poisson regression was used
to formally assess how, for each IOR, POMR changed over
calendar time [51]. “Total number of deaths” was used as
the outcome variable, “year” as independent variable and
“pop” (the total number of operations) as offset in the re-
gression equation. Rather than assuming a linear relation-
ship between calendar year and the log POMR over the en-
tire study period of 17 years (1998–2014), we generated
three consecutive time intervals based on tertiles of time
[52]. The first interval comprised the years 1998–2003
(6 years), the second comprised the years 2004–2009 (6
years), and the third comprised the years 2010–2014 (5
years). In the first step, the first interval served as reference
time period, with which the second and third intervals were
compared. In a second analysis, we compared the early and
the late period to the middle period. In a third step, sex-spe-
cific analyses of the age-adjusted effect of time on POMRs
were performed. All steps of the Poisson regression were
first completed for crude POMRs, and then for age- and
sex-adjusted POMRs. We report the regression results as
incident rate ratios (IRRs) with 95% confidence intervals
(CIs) [51, 53, 54].
Categorisation and ranking of results
Presentation of the results was determined after initial post
hoc exploration of the findings. Ranking was achieved by
sorting the IORs using Stata by (1) the age-adjusted POMR
time-trend direction (Poisson-regression [20, 51] results
for IRR of time interval 3 compared with interval 2 – de-
creasing, unchanged, or increasing [21]) over the study pe-
riod of 17 years, and (2) by incremental average directly
age-adjusted [36, 37] POMR levels (risk levels) over the
entire study period. The IRR of the late time interval 3
compared with time interval 2 was favoured as a ranking
criterion over the IRR of time interval 2 compared to the
early time interval 1, because the later time intervals ap-
pear more relevant for current developments in the periop-
erative setting.
Check of data completeness
For the included IORs, the .txt files for both the 2013 and
2014 data sets were visually checked. In addition, the data
overlapping both data sets (for the years 2004–2013) were
checked for consistency by subtracting the corresponding
data sets from one another in Excel, and these were accept-
ed if the result was 0. Inconsistencies and missing data in
the 2014 data set were found for IOR “G.3.1. hysterecto-
my”. In view of this inconsistency, only the data from the
2013 data set were used for the analysis except the regular-
ly included data for the year 2014.
Software
The following software was used: Data import – TextEdit®
version 1.12 (329) Copyright© 1995–2016 Apple Inc., Cu-
pertino, CA, U.S.; Microsoft Excel® for Mac, version
16.15 (180709) Copyright© 2018 Microsoft Corp., Red-
mond, WA, U.S.; Adobe Acrobat Reader DC, Continuous
Release, version 2018.011.20055, Copyright© 2003–2017
Solid Documents Limited, Nelson NZ; Preview Version
9.0 (909.18) Copyright© 2002–2016 Apple Inc. Data
analysis: Stata/IC 14.2 for Mac, Copyright© 1985–2015
StataCorp LLC, College Station, TX, U.S. Manuscript
preparation: Microsoft Word® for Mac, version 16.15
(180709) Copyright© 2018 Microsoft Corp. Literature ref-
erences: EndNote™ X8.2, Clarivate Analytics, Philadel-
phia, PA, U.S.
Results
Detailed results are given in figures 1–4, and table 2 and
table 3.
Indicator selection
The FOPH CH-IQI comprised 347 indicators in 2014.
Based on the inclusion and exclusion criteria, 325 indica-
tors could not be included: 232 indicators contained no da-
ta about age-and sex-specific mortality; 14 indicators con-
tained data about cardiosurgical procedures; 47 indicators
contained data about nonsurgical procedures/conditions;
16 indicators contained data about a surgical subgroup
(when an overall indicator was available); and 16 indica-
tors did not contain data for all years studied (1998–2014).
Thus, 22 indicators were included in the analysis (table 1).
Summary descriptive statistics
The analysis of the selected 22 IORs included 1,561,012
operations (cases) and 22,140 in-hospital deaths, with an
overall crude POMR of 1.42% over the study period
1998–2014. For 2014, all 22 IORs together represented
110,300 operations and 1506 deaths. Because a total of
63,938 people died in Switzerland in 2014, according to
the Federal Statistical Office [55], the deaths reflected by
these IORs represented 2.4% of the overall mortality in
Switzerland in 2014. IOR groups were categorised accord-
ing to the direction of POMR trends and to risk levels
(mean age-adjusted POMR 1998–2014). The results of the
direct age-adjustment and analysis of POMR time trends
are presented in table 2 and table 3, and graphically vi-
sualised in figures 1–4. The HSM-relevant [18, 31] IORs
pancreatic resection, oesophageal resection, and low resec-
tion of the rectum (part of the IOR group colorectal resec-
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tions) fell into the IOR result group that had an unchanged
time trend.
Impact of sex on POMR
Sex-specific IORs (hysterectomy, TUR prostate) included
307,375 operations (19.7% of all operations). Of the re-
maining 20 IORs, including 1,253,637 operations (80.3%
of all operations), 11 IORs including 858,657 operations
(68.5% of remaining operations) had significantly lower
POMRs in females; 8 IORs including 54,897 operations
(4.4% of remaining operations) had no sex difference.
POMRs were significantly higher for females in the IOR of
hernia repair without intestinal operation which included
340,083 operations (27.1% of remaining operations; IRR
1.86, 95% CI 1.51–2.29).
Discussion
We present the time trends of age-standardised periopera-
tive in-hospital mortality rates (POMRs) for selected non-
cardiac surgical indicator operations (IORs) published by
the Swiss FOPH for the years 1998–2014 for 22 noncar-
diac surgical IORs, representing 1,561,012 individual op-
erations and 22,140 in-hospital deaths, and corresponding
to an overall crude POMR of 1.42%. We found that the
long-term POMR time trends are not generally decreas-
ing in Switzerland. In contrast, for a substantial number of
IORs the POMRs did not change, and a few POMRs even
Table 1: Indicator operations (IOR) used by the Federal Office of Public Health (FOPH) and selected for time trend analysis.
Selected indicator operations Original German FOPH indicator name FOPH indicator
code
Cases
1998–2014
% (all) Deaths
1998–2014
Crude POMR
(%)
Cholecystectomy (no tumour) Cholezystektomie bei Gallensteinen und Cholezystitis,
ohne Tumor, Mortalität
E.1.1.M 183667 11.8 459 0.2
Arterial pelvic or leg aneurysm or dis-
section operation
OP an Becken-/Beinarterien bei Aneurysma/Dissek-
tion, Mortalität
F.3.7.M 2845 0.2 48 1.7
Femoral neck fracture Schenkelhalsfraktur (Alter >19), Mortalität I.3.1.M 85313 5.5 3623 4.2
Trochanteric fracture Pertrochantäre Fraktur (Alter >19), Mortalität I.3.8.M 74016 4.7 2887 3.9
Gastric, duodenal or jenjunal ulcer
resection (no tumour)
HD Ulcus von Magen, Duodenum oder Jejunum, ohne
Tumor, Mortalitä"
E.5.5.M 39871 2.6 1850 4.6
Major pulmonary or bronchial resec-
tion
Grössere Resektionen von Lunge oder Bronchien ins-
gesamt, Mortalität
D.4.1.M 32505 2.1 878 2.7
TUR prostate Prostata-TUR, Mortalität H.4.1.M 140853 9.0 287 0.2
Hernia repair without intestinal oper-
ation
Herniotomie ohne OP am Darm, Mortalität E.2.1.M 340083 21.8 395 0.1
Hysterectomy (benign disease) Hysterektomie bei gutartigen Erkrankungen (Alter
>14), Mortalität
G.3.1.M 166522 10.7 86 0.1
Extracranial vascular operation Extrakranielle Gefäss-OP, Mortalität F.1.1.M 14324 0.9 88 0.6
Nephrectomy Vollständige Nephrektomie, Mortalität H.1.1.M 15778 1.0 221 1.4
Amputation foot (no trauma) Amputation im Fussbereich, kein Trauma, Mortalität F.4.1.M 25420 1.6 710 2.8
Hernia repair with intestinal opera-
tion
Herniotomie mit OP am Darm, Mortalität E.2.2.M 4519 0.3 254 5.6
Gastric carcinoma resection Magenresektionen (ohne Ösophaguseingriff) bei Ma-
genkarzinom, Mortalität
E.5.2.M 5659 0.4 259 4.6
Nonruptured abdominal aortic
aneurysm (open operation)
Offene abdominale OP bei Aortenaneurysma nicht
rupturiert, Mortalität
F.2.2.M 5961 0.4 238 4.0
Arterial pelvic or leg thromboembolic
operation
OP an Becken-/Beinarterien bei arterieller Embolie/
Thrombose, Mortalität
F.3.5.M 6437 0.4 351 5.5
Colorectal resection Kolorektale Resektionen insgesamt, Mortalität E.4.1.M 147417 9.4 6771 4.6
Pancreatic resection Pankreasresektionen insgesamt (ohne Transplanta-
tion, Alter >19), Mortalität
E.7.1.M 10071 0.6 622 6.2
Complex oesophageal procedure Komplexe Eingriffe am Ösophagus, Mortalität E.6.1.M 4455 0.3 310 7.0
Hip endoprosthesis (first implant, no
fracture)
Hüft-Endoprothese-Erstimplantation (nicht bei Frak-
turen), Mortalität
I.1.1.M 238940 15.3 503 0.2
Cystectomy Entfernung der Harnblase (Zystektomie), Mortalität" H.3.5.M 6416 0.4 198 3.1
Amputation lower limb (no trauma) Amputation untere Extremität, kein Trauma, Mortalität F.4.2.M 9940 0.6 1102 11.1
Total 22 indicators 1561012 100.0 22140 1.4
Table 2: Summary results of POMR trends.
Groups categorised by trend direction
and risk
Risk (mean age-adjusted POMR
1998–2014, (%))
Cases % of cases Deaths % of deaths Crude POMR
(%)
1. Decreasing POMR trends in low to in-
termediate risk IOR
0.2–2.2 418217 26.8 9745 44.0 2.3
2. Unchanged POMR trends in low risk
IOR
0.1–0.9 702980 45.0 1787 8.1 0.3
3. Unchanged POMR trends in intermedi-
ate risk IOR
1.7–3.8 184519 11.8 8805 39.8 4.8
4. Increasing POMR trends in low to high
risk IOR
0.1–5.2 255296 16.4 1803 8.1 0.7
Unchanged or increasing 0.1–5.2 1143186 73.2 12395 56.0 1.1
All groups (1–4) 0.1–5.2 1561012 100.0 22140 100.0 1.4
POMR = perioperative mortality rate; IOR = indicator operation
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Table 3: Decreasing, unchanged, and increasing POMR time trends 1998–2014 for 22 indicator operations with various perioperative risk.
Indicator opera-
tion (IOR)
Cases Deaths POMR
crude
(%)
POMR
age-
adj
(%)
Adjustment IRR
1
IRR
2
95% CI p-
value
IRR
3.1
95% CI p-
value
IRR
3.2
95% CI p-
value
IRR
F/M
95% CI p-
value
1. Decreasing
POMR trends in
low to interme-
diate risk IOR
Cholecystectomy
(no tumour)
183,667 459 0.2 0.2 Crude 1 1.18 0.95–1.48 0.134 0.84 0.66–1.07 0.159 0.709 0.568–0.885 0.002
Age / Sex 1 1.11 0.89–1.39 0.337 0.75 0.58–0.95 0.018 0.669 0.536–0.835 0.000 0.58 0.48–0.69 0.000
Arterial pelvic or
leg aneurysm or
dissection oper-
ation
2845 48 1.7 0.6 Crude 1 0.84 0.43–1.62 0.595 0.35 0.17–0.76 0.007 0.425 0.209–0.863 0.018
Age / Sex 1 0.75 0.39–1.47 0.409 0.34 0.16–0.72 0.005 0.445 0.219–0.906 0.026 0.99 0.44–2.25 0.987
Femoral neck
fracture
85,313 3623 4.2 0.8 Crude 1 1.10 1.01–1.19 0.024 1.01 0.93–1.10 0.818 0.920 0.851–0.993 0.033
Age / Sex 1 1.05 0.97–1.14 0.264 0.94 0.87–1.02 0.159 0.900 0.833–0.972 0.007 0.50 0.47–0.54 0.000
Trochanteric
fracture
74,016 2887 3.9 0.9 Crude 1 1.01 0.92–1.11 0.835 0.95 0.87–1.04 0.266 0.940 0.863–1.025 0.159
Age / Sex 1 0.96 0.88–1.06 0.447 0.88 0.80–0.96 0.005 0.910 0.835–0.992 0.032 0.42 0.39–0.46 0.000
Gastric, duode-
nal or jejunal ul-
cer resection (no
tumour)
39,871 1850 4.6 1.7 Crude 1 1.04 0.93–1.16 0.495 0.84 0.75–0.94 0.003 0.808 0.722–0.904 0.000
Age / Sex 1 1.03 0.92–1.15 0.619 0.78 0.69–0.87 0.000 0.755 0.674–0.845 0.000 0.91 0.83–1.00 0.048
Major pulmonary
or bronchial re-
section
32,505 878 2.7 2.2 Crude 1 0.88 0.74–1.04 0.126 0.74 0.63–0.88 0.000 0.845 0.724–0.986 0.032
Age / Sex 1 0.88 0.74–1.04 0.136 0.73 0.62–0.86 0.000 0.830 0.711–0.968 0.018 0.59 0.51–0.69 0.000
2. Unchanged
POMR trends in
low risk IOR
TUR prostate 140,853 287 0.2 0.1 Crude 1 0.97 0.74–1.29 0.853 0.91 0.67–1.22 0.517 0.931 0.705–1.231 0.617
Age / Sex 1 0.98 0.74–1.29 0.871 0.89 0.66–1.20 0.447 0.912 0.690–1.206 0.519 11.08 2.74–44.79 0.001
Hernia repair
without intestinal
operation
340,083 395 0.1 0.1 Crude 1 0.97 0.76–1.24 0.799 0.97 0.76–1.24 0.809 1.001 0.792–1.265 0.993
Age / Sex 1 0.93 0.73–1.19 0.563 0.90 0.70–1.16 0.408 0.967 0.766–1.222 0.781 1.86 1.51–2.29 0.000
Hysterectomy
(benign disease)
166,522 86 0.1 0.1 Crude 1 0.79 0.49–1.28 0.342 0.58 0.33–1.02 0.057 0.735 0.415–1.301 0.291
Age / Sex 1 0.74 0.46–1.20 0.221 0.54 0.31–0.94 0.030 0.729 0.411–1.293 0.280 0.11 0.01–0.80 0.029
Extracranial vas-
cular operation
14,324 88 0.6 0.6 Crude 1 0.90 0.54–1.47 0.663 0.73 0.42–1.24 0.244 0.810 0.485–1.354 0.422
Age / Sex 1 0.88 0.53–1.46 0.625 0.67 0.39–1.16 0.155 0.761 0.455–1.273 0.299 1.06 0.68–1.66 0.791
Nephrectomy 15,778 221 1.4 0.8 Crude 1 0.95 0.69–1.31 0.754 0.99 0.71–1.38 0.940 1.039 0.755–1.430 0.814
Age / Sex 1 0.91 0.66–1.25 0.561 0.85 0.61–1.19 0.354 0.938 0.681–1.293 0.696 0.73 0.55–0.96 0.024
Amputation foot
(no trauma)
25,420 710 2.8 0.9 Crude 1 0.89 0.74–1.07 0.214 1.00 0.83–1.20 0.965 1.121 0.943–1.333 0.195
Age / Sex 1 0.85 0.70–1.02 0.081 0.90 0.75–1.08 0.260 1.063 0.893–1.264 0.492 0.67 0.57–0.79 0.000
3. Unchanged
POMR trends in
intermediate
risk IOR
Hernia repair
with intestinal
operation
4519 254 5.6 1.7 Crude 1 1.22 0.86–1.74 0.266 1.18 0.83–1.66 0.359 0.962 0.733–1.263 0.780
Age / Sex 1 1.19 0.84–1.70 0.324 1.25 0.89–1.77 0.202 1.049 0.798–1.377 0.733 0.83 0.64–1.06 0.140
Gastric carcino-
ma resection
5659 259 4.6 1.8 Crude 1 1.14 0.86–1.51 0.370 0.85 0.61–1.17 0.310 0.743 0.544–1.015 0.062
Age / Sex 1 1.17 0.88–1.55 0.283 0.86 0.62–1.19 0.370 0.739 0.541–1.009 0.057 0.60 0.46–0.78 0.000
Unruptured ab-
dominal aortic
aneurysm (open
operation)
5961 238 4.0 1.9 Crude 1 0.87 0.63–1.19 0.388 0.96 0.69–1.33 0.785 1.099 0.816–1.481 0.536
Age / Sex 1 0.83 0.60–1.14 0.245 0.90 0.65–1.26 0.551 1.093 0.810–1.474 0.560 1.23 0.88–1.72 0.232
Arterial pelvic or
leg thromboem-
bolic operation
6437 351 5.5 2.1 Crude 1 1.08 0.80–1.46 0.626 1.09 0.81–1.45 0.576 1.007 0.797–1.273 0.954
Age / Sex 1 1.10 0.81–1.49 0.536 1.06 0.79–1.41 0.715 0.959 0.758–1.213 0.724 1.01 0.81–1.27 0.904
Colorectal resec-
tion
147,417 6771 4.6 2.2 Crude 1 1.13 1.06–1.20 0.000 1.17 1.10–1.25 0.000 1.041 0.985–1.100 0.154
Age / Sex 1 1.12 1.06–1.19 0.000 1.15 1.08–1.23 0.000 1.027 0.972–1.085 0.336 0.75 0.72–0.79 0.000
Pancreatic re-
section
10,071 622 6.2 3.4 Crude 1 1.09 0.89–1.35 0.406 1.19 0.97–1.46 0.099 1.088 0.910–1.301 0.352
Age / Sex 1 1.02 0.83–1.27 0.823 1.08 0.87–1.32 0.490 1.050 0.878–1.256 0.591 0.74 0.63–0.87 0.000
Complex oe-
sophageal pro-
cedure
4455 310 7.0 3.8 Crude 1 1.05 0.80–1.37 0.747 0.88 0.67–1.16 0.367 0.841 0.642–1.102 0.209
Age / Sex 1 0.97 0.74–1.27 0.825 0.80 0.60–1.06 0.120 0.826 0.630–1.082 0.165 0.99 0.77–1.28 0.941
4. Increasing
POMR trends in
low to high risk
IOR
Hip endopros-
thesis (first im-
238,940 503 0.2 0.1 Crude 1 0.58 0.46–0.72 0.000 0.76 0.62–0.94 0.010 1.317 1.061–1.635 0.013
Age / Sex 1 0.57 0.46–0.72 0.000 0.72 0.59–0.89 0.002 1.261 1.016–1.566 0.036 0.73 0.61–0.87 0.000
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Indicator opera-
tion (IOR)
Cases Deaths POMR
crude
(%)
POMR
age-
adj
(%)
Adjustment IRR
1
IRR
2
95% CI p-
value
IRR
3.1
95% CI p-
value
IRR
3.2
95% CI p-
value
IRR
F/M
95% CI p-
value
plant, no frac-
ture)
Cystectomy 6416 198 3.1 1.3 Crude 1 1.00 0.67–1.50 0.990 1.80 1.25–2.61 0.002 1.798 1.302–2.484 0.000
Age / Sex 1 0.93 0.62–1.39 0.714 1.58 1.09–2.29 0.017 1.701 1.231–2.352 0.001 0.98 0.72–1.35 0.924
Amputation low-
er limb (no trau-
ma)
9940 1102 11.1 5.2 Crude 1 1.01 0.88–1.17 0.851 1.24 1.07–1.44 0.004 1.223 1.056–1.417 0.007
Age / Sex 1 1.05 0.91–1.21 0.517 1.28 1.10–1.48 0.001 1.218 1.051–1.410 0.009 0.91 0.80–1.03 0.146
Total 1,561,012 22,140 1.4
POMR = perioperative mortality rate; IOR = indicator operation; age-adj = age-adjusted; IRR = incident-rate ratio; IRR 1 = reference for comparing three consecutive time intervals
and is therefore 1 for first period; IRR 2 = IRR for comparison time intervals 2/1; IRR 3.1 = IRR for comparing time intervals 3/1; IRR 3.2 = IRR for comparing time intervals 3/2;
95% CI = 95% confidence interval; IRR F/M = IRR for testing impact of female (versus male) sex on POMR; p = two-tailed p-value.
increased. Female sex was associated with a lower POMR
in most IORs. The methods used represent a way of calcu-
lating and presenting POMR trends that could be adopted
for routine use.
The strengths of our study are the completeness of the na-
tional data sets for IORs, the availability of data for all
years of the study period for selected IORs, and the better
comparability of yearly populations after direct age stan-
dardisation. However, a number of limitations need to be
considered [56]. First, operations, not patients, represent
the individual observations in the publicly available FOPH
data, and hence the denominator for the POMR. Because
one patient could have represented several cases in some
IORs, a case-based POMR may theoretically underesti-
mate a patient-based POMR. Second, the results may be
affected by bias – selection bias may have been introduced
by selecting IORs according to the inclusion and exclu-
sion criteria. In particular, IORs for which reporting be-
Figure 1: Decreasing POMR trends in low- to intermediate-risk
IORs.Note: POMR = perioperative mortality rate.
gan after 1998 were not included. Within the individual
IOR data, bias may have been introduced during the re-
porting process. Third, IOR data may have been signif-
icantly influenced by varying coding practices in hospi-
tals, for example after the introduction of diagnosis-related
group (DRG)-based quality reporting and reimbursement
in Switzerland on January 1, 2012 (SwissDRG) [57]. In-
deed, several international studies have documented faulty,
missing or incorrect coding of diagnoses and procedures
after introduction of DRG [58–60], restructuring of proce-
dure codes [61], and changes in comorbidity coding [62].
After the introduction of SwissDRG in 2012, readmission
within 18 days leads to coding of the readmission as one
hospital stay or case together with the initial hospitalisation
[63]. Whereas DRG-related comorbidity coding is unlikely
to have impacted our results significantly (comorbidity da-
Figure 2: Unchanged POMR trends in low-risk IORs.Note: POMR
= perioperative mortality rate. Sex-specific analyses were not com-
pleted for sex-specific operations (hysterectomy, TUR prostate;
see methods section). Note that different percentage scales are
used for the upper three and the lower three IORs.
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ta were not part of the analysed data sets), the changed
readmission coding might have influenced our results: If
a patient died in hospital after readmission, this may have
escaped coding as POM before introduction of SwissDRG,
but should have been captured afterwards. This coding rule
may have led to higher in-hospital POMRs in the last of
the three time intervals we defined. However, this poten-
tial impact is not related to the type of IOR and might af-
fect all POMR trends, not only increasing POMR trends.
Notably, a recent study reported no relationship between
Figure 3: Unchanged POMR trends in intermediate-risk
IORs.Note: POMR = perioperative mortality rate.
Figure 4: Increasing POMR trends in low- to high-risk IORs.Note:
POMR = perioperative mortality rate. Note also that different per-
centage scales are used for the first IOR and the second and third
IOR.
SwissDRG introduction and intensive care unit mortality
in Switzerland [64]. The data sets analysed in our analy-
sis, however, did not allow us to further investigate these
issues. Fourth, the data and results may have been affect-
ed by changes in the organisation and delivery of health-
care. In Switzerland, the mandatory reporting of quality
indicators is limited to inpatients. A recent project to ex-
tend such reporting to the ambulatory setting has not yet
been fully implemented [65, 66], and procedures may have
been shifted from the inpatient to the ambulatory setting
in Switzerland during the study period, in line with in-
ternational trends (e.g., TUR prostate [67], hysterectomy
[68], hip arthroplasty [69], colectomy [70], cholecystec-
tomy [71]). Furthermore, in-hospital mortality (used for
FOPH IOR [13]) may overestimate [72] or underestimate
[73] 30-day mortality [72, 74]. Postoperative patient trans-
fers to secondary institutions may have affected the data
and reporting [75]. Fifth, owing to the limitations of the
FOPH data used in this analysis, we could not assess if
trends differed for emergency interventions compared to
non-emergency interventions.
The results of this analysis should be interpreted cautiously
in light of the study objectives and limitations, and pre-
existing evidence [75].The study objective was to analyse
POMR time trends for selected IORs at the national level
from a public health perspective on monitoring the overall
performance of the healthcare system [1]. A comprehen-
sive exploration of the specific conditions and causes of in-
dividual IOR trends is beyond the objectives of this study
and of the presented monitoring approach, and should be
addressed by more detailed investigations [7]. Indeed, the
POMR has limited value at the level of individual hospi-
tals, where the case mix may vary [76], but is increasingly
used as a quality indicator for monitoring the overall per-
formance of surgical healthcare at the regional or national
level [1, 3, 4, 8] and has been recommended by the WHO
[5] and the Lancet Commission on Global Surgery [6, 7] as
a core healthcare indicator.
What could be the utility of using POMR trends as a
surveillance instrument for monitoring the overall perfor-
mance of surgical care at the national level? Some of our
results deviate from evidence that has been reported in the
international literature, highlighting the importance of in-
dividually monitoring the performance of healthcare sys-
tems, because organisational, population-based and other
factors may differ between countries. In contrast to our
findings, decreasing POMR trends for high-risk proce-
dures have been reported in the US, which may be related
to the inclusion of different IORs or to other factors [77].
For cystectomy, in-hospital mortality was unchanged from
2001–2008 in the US [78], and 30-day and 90-day mor-
tality decreased between 1998 and 2010 in England [79].
According to an Australian single-centre study, the 30-day,
6-month and 1-year mortality after major lower limb am-
putation decreased dramatically between 2000–2002 and
2010–2012, which was attributed, in part, to organisational
changes [80]. A study from the US then reported declining
in-hospital mortality from 1998–2008 after total hip arthro-
plasties despite increasing trends in in-hospital major com-
plications, but because the length of hospital stay also de-
creased significantly during the same period, the authors
point out that some of the postoperative deaths may have
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occurred after the transfer of the patients to other facilities
[75]. In addition to these international findings, lower hos-
pital volume was associated with higher mortality after oe-
sophageal, gastric, pancreatic and rectal cancer resections
in a Swiss study (1999–2012) [81]. This study also docu-
mented an increasing concentration of these procedures in
centres with higher volumes, but the overall POMR trends
for these procedures are not evident from this study [81].
The external validity [56] of our findings is crucial for
their potential transfer to practice. The results for individ-
ual IORs are based on mandatory data collection for all
Swiss hospitals and represent a national census rather than
a sample for the respective indicator. Importantly, routine
quality reporting of surgical outcomes has been found to
have a beneficial effect on quality outcomes per se [82,
83], and to be effective for measuring the impact of quality
improvement strategies on mortality [84]. Allowing for the
limitations of the routine data collection processes and the
specific indicator definitions, POMR trends for individual
FOPH IORs appear to be valid for use as indicators for pe-
rioperative care at the national level in Switzerland. The
presented approach of calculating and presenting POMR
trends based on direct standardisation and trend analysis
using Poisson regression is methodically straightforward
and could be done regularly to complement the reports of
the FOPH.
Conclusion
For 73% of the included cases of selected noncardiac sur-
gical indicator operations, in-hospital POMR trends in
Switzerland were unchanged or increasing from
1998–2014. Potential confounding factors include changes
in the coding practices and in the organisation of healthcare
delivery. Unexpected POMR trends should be further in-
vestigated to identify potentially preventable factors
amenable to national quality improvement strategies or to
detect practice variations related to the reporting and cod-
ing process. The presented methodology may be used to
monitor POMRs at the national level in Switzerland.
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Appendix 1
Technical appendix
Legal background, data collection, processing, and
controlling processes
Swiss hospitals collect data yearly according to variables
defined by the medical statistics of hospitals [22]. Hos-
pitals can check data plausibility using software provided
by the Federal Statistical Office [13]. Mortality always de-
fines a case as an “inpatient” hospital stay [22]. Hospitals
send the data to the Cantonal Statistical Offices, which or-
ganise and supervise data collection, check data quality,
validate the data sets, and transfer them to the Federal Sta-
tistical Office. The Federal Statistical Office, responsible
for the data collection at the federal level, publishes the
medical statistics of hospitals [22] and transfers the neces-
sary data required to establish the CH-IQIs to the FOPH
[13].
Data import and file preparation – Data import, clear-
ance, preparation of files and variables
To reconstruct all omitted age group observations, includ-
ing sex-specific layers, a full set of age group observations
for one year was first inserted as a “dummy” year at the
end of the data list after sorting the “year” variable. The
“dummy” observations contained 2050 as a “year” value to
avoid confusion with real values in the data set, as well as a
complete range of age groups (1–20) with two sex-specific
layers (1=male, 2=female), resulting in 40 observations for
“2050”. The observations of “year=2050” generated cor-
responding complete values (1–40) for “agegr” and “sex”,
which were used temporarily as templates for all possi-
ble interactions between “year” and “agegr”, allowing the
Stata command “fillin” [34] to generate a rectangular data
structure and fill in omitted observations and their values
as “missing”. The “fillin”-generated missing values were
then replaced by zeros, and the 40 “dummy observations”
were deleted.
Direct standardisation using the 2013 European Stan-
dard Population
As a standard population, the 2013 European Standard
Population (ESP) was used (including the recommendation
not to disaggregate the standard population by sex [19]).
The FOPH publishes age-group-specific data for the fol-
lowing 20 5-year strata: age group 1 = 0–4 yrs, 2 = 5–9
yrs; 3 = 10–14 yrs; 4 = 15–19 yrs; 5 = 20–24 yrs, etc., until
18 = 85–89 yrs; 19 = 90–94 yrs; and 20 = 95+ yrs. These
age groups deviate minimally from the ESP, where the
youngest group is divided into two groups 0–<1 and 1–4
[19]. For this project (adults), the ESP-based standard pop-
ulation was adapted to the FOPH groups, combining the
first two into one group (1–4 years), with a strata-specif-
ic combined population of 1000+4000=5000 [19]. A Stata
file was created accordingly, containing variables with the
adapted age group and population size variables.
Direct standardisation
Directly standardised POMRs were calculated using the
Stata command “distrate” [36, 37]. The “distrate” com-
mand calculates the standardised rates and 95% confidence
intervals (95% CIs) for standardised rates and is used, for
example, in cancer registries [37]. “distrate” offers sever-
al options for calculating 95% CIs that are based on dif-
ferent assumptions about the underlying data distribution
[37]. We used the method proposed by Dobson et al. [38]
based on the χ2 distribution for the calculation of 95% CIs.
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